Neuropsychopharmacology is a multidisciplinary field that explores the effects of drugs on the brain and behavior, with the goal of understanding and treating neuropsychiatric disorders. It encompasses the study of the mechanisms of action of psychoactive substances, their effects on neurotransmitter systems, and their impact on cognitive, emotional, and behavioral processes. By elucidating the neurobiological basis of psychiatric disorders and the pharmacological mechanisms of psychoactive drugs, neuropsychopharmacology aims to develop novel treatments that target specific neural circuits and molecular pathways implicated in mental illness.
Research in neuropsychopharmacology spans a wide range of topics, including the neurochemistry of neurotransmitters such as dopamine, serotonin, and glutamate, the pharmacology of psychotropic medications, the neurobiology of addiction and substance abuse, and the development of novel pharmacological interventions for psychiatric disorders. Advances in neuroscience techniques, such as neuroimaging, electrophysiology, and molecular biology, have revolutionized our understanding of brain function and dysfunction and have led to the identification of new drug targets and treatment approaches. By integrating insights from basic science research with clinical observations, neuropsychopharmacologists strive to translate scientific discoveries into effective treatments that improve the lives of individuals with neuropsychiatric disorders.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Genetic decoupling and global regulatory failure in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : An unusual perspective for understanding and preventing bulimia relapse: Unhealthy sibling loyalty
Karen Gail Lewis, Private Practice, United States